Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00747227 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL)
A Phase 3 study of Cataract, sponsored by Abbott Medical Optics.
- Completed
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
- 11
- Study locations
NCT00747227: Completed Phase 3 study of Cataract, sponsored by Abbott Medical Optics.
NCT00747227 is a Phase 3 study of Cataract that has completed, run by Abbott Medical Optics. The registered enrollment target is 250 participants, above the 225-participant average among 83 other Cataract trials with a reported enrollment target (11% higher). The trial reports 11 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00747227, a Phase 3 study of Cataract, has completed, sponsored by Abbott Medical Optics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of a new investigational modified light transmission monofocal intraocular lens compared to a conventional intraocular lens (IOL).
Primary Outcome
Snellen Equivalent visual acuity of 20/40 or better
Conditions Studied
Interventions
- DEVICE modified light transmission intraocular lens
- DEVICE monofocal acrylic intraocular lens
Study Locations (11)
Pennsylvania
- William Christie, M.D. - Cranberry Township
- Mark Blecher, M.D. - Philadelphia
Arizona
- Patrick Aiello, M.D. - Scottsdale
Arkansas
- Randall E. Cole, M.D. - Rogers
Connecticut
- Aron Rose, M.D. - New Haven
Minnesota
- Y. Ralph Chu, M.D. - Bloomington
Missouri
- Steven Silverstein, M.D. - Kansas City
Oregon
- Jon-Marc Weston, M.D. - Roseburg
Rhode Island
- Robert L. Bahr, M.D. - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2006-12 |
| Est. Completion | 2009-06 |
| Phase | Phase 3 |
What the finished NCT00747227 record still lists
NCT00747227 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 225-participant average among 83 other Cataract trials with a reported enrollment target (11% higher).
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 2 interventions - of which modified light transmission intraocular lens is the first listed.
NCT00747227 lists 11 locations in 10 states (Pennsylvania, Arizona, Arkansas).
Frequently Asked Questions
What is clinical trial NCT00747227 about?
NCT00747227 is a clinical study titled "Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL)". The purpose of this study is to evaluate the safety and effectiveness of a new investigational modified light transmission monofocal intraocular lens compared to a conventional intraocular lens (IOL).
What is the current status of trial NCT00747227?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2006-12. Estimated completion is 2009-06.
What conditions does trial NCT00747227 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT00747227?
The interventions under investigation include: modified light transmission intraocular lens (DEVICE), monofocal acrylic intraocular lens (DEVICE).
Who is sponsoring clinical trial NCT00747227?
This trial is sponsored by Abbott Medical Optics, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00747227 being conducted?
This trial has 11 study locations across Arizona, Arkansas, Connecticut, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00747227's enrollment target sits among peer trials
250 21st of 83 higher than 62 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
RECRUITING · Phase 3
-
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
RECRUITING · Phase 3
-
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
RECRUITING · Phase 3
-
Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation
COMPLETED · Phase 3
-
Study of T-PRED(TM) Compared to Pred Forte(R) II
COMPLETED · Phase 3
-
Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia